Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 29.02M | £ 26.74M | £ 23.82M | £ 30.27M | £ 29.82M |
Total Assets | £ 281.36M | £ 255.02M | £ 230.92M | £ 209.92M | £ 213.19M |
Total Debt | £ 84.14M | £ 64.22M | £ 42.27M | £ 29.76M | £ 40.48M |
Net Debt | £ 55.12M | £ 37.48M | £ 18.45M | £ -509.00K | £ 10.65M |
Total Liabilities | £ 138.05M | £ 115.87M | £ 97.05M | £ 78.11M | £ 81.14M |
Stockholders Equity | £ 143.31M | £ 139.15M | £ 133.88M | £ 131.80M | £ 132.06M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |